Oxford Science Enterprises portfolio companies
Updated 16 Nov 2026
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Company | City | Last round | Amount | Date |
|---|---|---|---|---|
| Fractile | London | Series C | $771.2M | 2026-10-29 |
| Salience Labs | Oxford | Series B | $125.0M | 2026-10-14 |
| Oxford Quantum Circuits | Reading | Series C | $350.0M | 2026-06-03 |
| Quantrol Ox | Espoo | Series A | $13.5M | 2026-10-22 |
| Living Optics | Milton Keynes | Series A | $20.0M | 2026-09-24 |
| Beacon Therapeutics | Alachua | Series C | $75.0M | 2026-01-08 |
| Genomics | Oxford | Series C | $44.6M | 2024-01-08 |
| Sitryx Therapeutics | Oxford | Series A | $39.0M | 2023-09-27 |
8 rows of the CSV in 5 of its 18 columns.
- The 25 Oxford Science Enterprises portfolio companies have raised $2.5B in total.
- 7 of them closed their most recent round in the last 12 months, $1.4B combined.
- The largest of those rounds is Fractile's $771.2M Series C, dated October 2026.
- Parkwalk Advisors is an investor in 7 of them, more than any other fund.
- Software is the most common sector, with 18 companies (72%).
- 24% were founded in 2020 or later; the median founding year is 2017.
- The most common team size is 11 to 50 employees (44% of companies with a recorded size).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Newest rounds
17 of 25| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| Fractile | Fractile develops semiconductor hardware and AI inference systems for large language model processing. | Artificial intelligence | London, United Kingdom | Series C | $771.2M | 2026-10-29 | $1.0B | Inovia Capital, Oxford Science Enterprises, Kindred Capital +1 | 101 to 250 | 2022 |
| Quantrol Ox | QuantrolOx builds machine learning control software that tunes and stabilizes qubits for quantum technologies. | Artificial intelligence | Espoo, Finland | Series A | $13.5M | 2026-10-22 | $21.5M | European Innovation Council, Oxford Science Enterprises, Voima Ventures +1 | 11 to 50 | 2021 |
| Salience Labs | Salience Labs develops optical networking technology using silicon photonics, electronics, and machine learning. | Artificial intelligence | Oxford, United Kingdom | Series B | $125.0M | 2026-10-14 | $166.5M | Oxford Science Enterprises, Cambridge Innovation Capital, Deeptech Labs +2 | 51 to 100 | 2021 |
| Living Optics | Living Optics develops imaging technology. | Artificial intelligence | Milton Keynes, United Kingdom | Series A | $20.0M | 2026-09-24 | $49.3M | Octopus Ventures, Oxford Science Enterprises, Outsized Ventures +2 | 11 to 50 | 2020 |
| Covatic | Covatic uses mobile-based algorithms to personalize app experiences for individual users. | Artificial intelligence | Birmingham, United Kingdom | Series B | $2.0M | 2026-06-25 | $9.0M | Techstars, Parkwalk Advisors, Oxford Science Enterprises +1 | 11 to 50 | 2016 |
| Oxford Quantum Circuits | Oxford Quantum Circuits develops quantum computers for scientific discovery. | Hardware | Reading, United Kingdom | Series C | $350.0M | 2026-06-03 | $496.4M | SBI Investment, Parkwalk Advisors, IP Group +2 | 101 to 250 | 2017 |
| Beacon Therapeutics | Beacon Therapeutics develops treatments to preserve and restore vision for eye diseases. | Biotech | Alachua, United States | Series C | $75.0M | 2026-01-08 | $365.1M | Oxford Science Enterprises, Forbion Capital Partners, Advent Life Sciences +1 | 101 to 250 | 2023 |
| Oxford Endovascular | Oxford Endovascular develops a novel treatment for brain aneurysms. | Biotech | Oxford, United Kingdom | Series A | $10.2M | 2024-05-20 | $28.4M | Innovate UK, MedTech Innovator, Parkwalk Advisors +1 | 1 to 10 | 2015 |
| Genomics | Genomics plc works to bring genomic medicine into healthcare. | Biotech | Oxford, United Kingdom | Series C | $44.6M | 2024-01-08 | $135.4M | Innovate UK, IP Group, Oxford Science Enterprises +1 | 101 to 250 | 2014 |
| Proxisense | Proxisense develops extreme environment proximity sensors and fluid contamination systems. | Hardware | Oxford, United Kingdom | Series A | $1.3M | 2023-11-24 | Parkwalk Advisors, Oxford Science Enterprises, Future Planet Capital | 11 to 50 | 2014 | |
| Sitryx Therapeutics | Sitryx Therapeutics develops disease-modifying therapeutics in immuno-oncology and immuno-inflammation. | Biotech | Oxford, United Kingdom | Series A | $39.0M | 2023-09-27 | Sofinnova Partners, Oxford Science Enterprises, SV Health Investors +1 | 11 to 50 | 2018 | |
| Navenio | Navenio provides indoor location positioning services through its mobile app. | Software | Oxford, United Kingdom | Series A | $6.3M | 2023-09-20 | Innovate UK, Future Planet Capital, IP Group +1 | 11 to 50 | 2015 | |
| Brill Power | Brill Power develops battery management technology and a Battery Intelligence Platform. | Energy | Oxford, United Kingdom | Series A | $10.5M | 2022-07-19 | $10.6M | Oxford Science Enterprises, Shell Ventures, Oxford University Innovation +1 | 11 to 50 | 2016 |
| ONI | ONI makes super-resolution microscopy accessible to new generations of researchers. | Biotech | Oxford, United Kingdom | Series B | $75.0M | 2021-12-24 | $109.4M | Puhua Capital, Future Planet Capital, Oxford Science Enterprises +2 | 101 to 250 | 2016 |
| Zegami | Zegami provides explainable imaging AI tools and machine learning services for end-to-end image analysis. | Artificial intelligence | Oxford, United Kingdom | Series B | $1.6M | 2019-07-15 | Parkwalk Advisors, Future Planet Capital, Oxford Science Enterprises +1 | 1 to 10 | 2016 | |
| Edplus | Edplus makes learning easier for everyone. | Artificial intelligence | Oxford, United Kingdom | Pre-seed | $643K | 2018-08-28 | Oxford Science Enterprises | 1 to 10 | 2018 | |
| EnzBond | EnzBond develops enzymes for pharmaceutical use through in-silico methods. | Biotech | Oxford, United Kingdom | Seed | $445K | 2016-12-05 | Oxford Science Enterprises | 1 to 10 | 2016 |
Table 1. Oxford Science Enterprises portfolio companies: the 17 newest rounds whose row carries a description, a city, a named fund and an amount. Source: FundingWatcher. Data as of 16 November 2026. Base: 25.
Largest rounds
Last 12 months| # | Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Fractile | Fractile develops semiconductor hardware and AI inference systems for large language model processing. | Artificial intelligence | London, United Kingdom | Series C | $771.2M | 2026-10-29 | $1.0B | Inovia Capital, Oxford Science Enterprises, Kindred Capital +1 | 101 to 250 | 2022 |
| 2 | Oxford Quantum Circuits | Oxford Quantum Circuits develops quantum computers for scientific discovery. | Hardware | Reading, United Kingdom | Series C | $350.0M | 2026-06-03 | $496.4M | SBI Investment, Parkwalk Advisors, IP Group +2 | 101 to 250 | 2017 |
| 3 | Salience Labs | Salience Labs develops optical networking technology using silicon photonics, electronics, and machine learning. | Artificial intelligence | Oxford, United Kingdom | Series B | $125.0M | 2026-10-14 | $166.5M | Oxford Science Enterprises, Cambridge Innovation Capital, Deeptech Labs +2 | 51 to 100 | 2021 |
| 4 | Beacon Therapeutics | Beacon Therapeutics develops treatments to preserve and restore vision for eye diseases. | Biotech | Alachua, United States | Series C | $75.0M | 2026-01-08 | $365.1M | Oxford Science Enterprises, Forbion Capital Partners, Advent Life Sciences +1 | 101 to 250 | 2023 |
| 5 | Living Optics | Living Optics develops imaging technology. | Artificial intelligence | Milton Keynes, United Kingdom | Series A | $20.0M | 2026-09-24 | $49.3M | Octopus Ventures, Oxford Science Enterprises, Outsized Ventures +2 | 11 to 50 | 2020 |
| 6 | Quantrol Ox | QuantrolOx builds machine learning control software that tunes and stabilizes qubits for quantum technologies. | Artificial intelligence | Espoo, Finland | Series A | $13.5M | 2026-10-22 | $21.5M | European Innovation Council, Oxford Science Enterprises, Voima Ventures +1 | 11 to 50 | 2021 |
| 7 | Covatic | Covatic uses mobile-based algorithms to personalize app experiences for individual users. | Artificial intelligence | Birmingham, United Kingdom | Series B | $2.0M | 2026-06-25 | $9.0M | Techstars, Parkwalk Advisors, Oxford Science Enterprises +1 | 11 to 50 | 2016 |
Table 2. Oxford Science Enterprises portfolio companies: the 7 largest rounds of the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most active investors
By companies backed| # | Investor | Type | Location | Companies | Share | Funded, 12 months | Latest |
|---|---|---|---|---|---|---|---|
| 1 | Parkwalk Advisors | Venture capital firm | London, United Kingdom | 7 | 28% | 2 | Covatic, Oxford Quantum Circuits |
| 2 | IP Group | Venture capital firm | London, United Kingdom | 3 | 12% | 1 | Oxford Quantum Circuits |
| 3 | Innovate UK | Entrepreneurship program | Swindon, United Kingdom | 3 | 12% | ||
| 4 | Future Planet Capital | Venture capital firm | London, United Kingdom | 3 | 12% | ||
| 5 | Oxford Investment Consultants LLP | Micro VC fund | Oxford, United Kingdom | 2 | 8% | 2 | Salience Labs, Living Optics |
| 6 | Oxford University Innovation | University program | Oxford, United Kingdom | 2 | 8% | ||
| 7 | Inovia Capital | Venture capital firm | Montréal, Canada | 1 | 4% | 1 | Fractile |
| 8 | Cocoa | Angel group | London, United Kingdom | 1 | 4% | 1 | Fractile |
| 9 | Kindred Capital | Venture capital firm | London, United Kingdom | 1 | 4% | 1 | Fractile |
| 10 | Silicon Catalyst | Startup accelerator | Santa Clara, United States | 1 | 4% | 1 | Salience Labs |
| 11 | Cambridge Innovation Capital | Venture capital firm | Cambridge, United Kingdom | 1 | 4% | 1 | Salience Labs |
| 12 | Deeptech Labs | Startup accelerator | Cambridge, United Kingdom | 1 | 4% | 1 | Salience Labs |
| 13 | SBI Investment | Venture capital firm | Minato, Japan | 1 | 4% | 1 | Oxford Quantum Circuits |
| 14 | HiJoJo Partners | Private equity firm | Nishi, Japan | 1 | 4% | 1 | Oxford Quantum Circuits |
| 15 | REMUS Capital | Venture capital firm | Boston, United States | 1 | 4% | 1 | Quantrol Ox |
Table 3. Oxford Science Enterprises portfolio companies: the funds recorded as investors in the most companies. Latest: companies they back that raised in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Sectors
| Sectors | Companies | Share | Total raised |
|---|---|---|---|
| Software | 18 | 72% | $2.0B |
| Health care | 10 | 40% | $599.5M |
| Artificial intelligence | 9 | 36% | $1.3B |
| Biotech | 9 | 36% | $638.3M |
| Hardware | 7 | 28% | $1.8B |
| Fintech | 2 | 8% | $52.5M |
| Cybersecurity | 1 | 4% | $49.3M |
| Energy | 1 | 4% | $10.6M |
| Education | 1 | 4% |
Table 4. Oxford Science Enterprises portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Funding stage
Table 5. Oxford Science Enterprises portfolio companies by stage of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Companies | Share |
|---|---|---|
| United Kingdom | 21 | 84% |
| United States | 3 | 12% |
| Finland | 1 | 4% |
Table 6. Oxford Science Enterprises portfolio companies by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
| Cities | Companies | Share |
|---|---|---|
| Oxford | 13 | 52% |
| London | 2 | 8% |
| Reading | 1 | 4% |
| Espoo | 1 | 4% |
| Milton Keynes | 1 | 4% |
| Alachua | 1 | 4% |
| Summertown | 1 | 4% |
| Birmingham | 1 | 4% |
| Abingdon | 1 | 4% |
| Elizabethtown | 1 | 4% |
| San Francisco | 1 | 4% |
| Thame | 1 | 4% |
Table 7. Oxford Science Enterprises portfolio companies by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Rounds by month
| Rounds by month | Companies | Share | Raised |
|---|---|---|---|
| October 2026 | 3 | 43% | $909.6M |
| September 2026 | 1 | 14% | $20.0M |
| June 2026 | 2 | 29% | $352.0M |
| January 2026 | 1 | 14% | $75.0M |
Table 8. Oxford Science Enterprises portfolio companies: most recent round by month, last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Most recent round by year
| Most recent round by year | Companies | Share | Raised |
|---|---|---|---|
| 2026 | 7 | 28% | $1.4B |
| 2024 | 3 | 12% | $104.8M |
| 2023 | 5 | 20% | $68.2M |
| 2022 | 3 | 12% | $29.1M |
| 2021 | 1 | 4% | $75.0M |
| 2019 | 3 | 12% | $3.1M |
Table 9. Oxford Science Enterprises portfolio companies by year of the most recent round. Source: FundingWatcher. Data as of 16 November 2026.
Founding year
| Founding year | Companies | Share |
|---|---|---|
| 2023 or later | 1 | 4% |
| 2020 to 2022 | 5 | 20% |
| 2015 to 2019 | 17 | 68% |
| 2010 to 2014 | 2 | 8% |
Table 10. Oxford Science Enterprises portfolio companies by founding year. Source: FundingWatcher. Data as of 16 November 2026.
Team size
| Team size | Companies | Share |
|---|---|---|
| 1 to 10 | 7 | 28% |
| 11 to 50 | 11 | 44% |
| 51 to 100 | 2 | 8% |
| 101 to 250 | 5 | 20% |
Table 11. Oxford Science Enterprises portfolio companies by headcount. Source: FundingWatcher. Data as of 16 November 2026.
Method
- A company is on this list when Oxford Science Enterprises is recorded as one of its investors. On 16 November 2026 that is 25 companies.
- Stage, round, amount and date are those of the company's most recent funding round. Amounts are in US dollars as the source records them.
- The table prints the 17 newest rounds whose row is complete: a one-sentence description, a city, a named fund and an amount. The CSV carries all 25 rows: 3 have no round amount, 0 no city and 5 no website. The CSV carries domain, website, LinkedIn and the cached description sentence where present.
Sources, fields and exclusions of both files: Method.
Questions
- How many Oxford Science Enterprises portfolio companies are on the list?
- 25, in the file dated 16 November 2026. 7 of them closed their most recent round in the last 12 months.
- What does the CSV contain?
- One row per company, 18 columns: name, domain, website, linkedin, description, founded, employees, city, region, country, sectors, funding_stage, last_round, last_round_date, last_round_usd, total_raised_usd, rounds, investors.
- How much does the list cost?
- $29 one-time for all 25 rows, no account. Every investor and every startup, two files, cost $99. With founder contacts, up to 2 founders or CEOs per company compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV download link, on the page after payment and by mail.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.